Released Nov 19, 2012, after the close
10-Q filed Nov 19, 2012, 50 days after period end · 0001437749-12-011966
Q3 2012 · 10-Q
Revenue$409.92K$409.92K −28.6% vs Q3 2011−23.1% vs Q2 2012
Net Income-$232.61K-$232.61K N/M vs Q3 2011N/M vs Q2 2012
EPS Diluted$0.00$0.00 N/M vs Q3 2011N/M vs Q2 2012
Gross Profit$310,652−14.5%
Operating Income-$226,415N/M
Operating Cash Flowderived$53,534−66.3%
Margins · derived
Gross margin75.8%+12.5 pt vs Q3 2011
Operating margin-55.2%+37.8 pt vs Q3 2011
Net margin-56.7%+37.3 pt vs Q3 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $409.92K | $574.09K | $546.38K |
| Net Income | -$232.61K | -$540.17K | -$943.79K |
| EPS Diluted | $0.00 | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR